SkinHealth Systems Inc
Avatud
0.63 -8.7
Ülevaade
Aktsiahinna muutus
24h
Min
0.62
Max
0.69
Sissetulek | 1.5M -6.6M |
|---|---|
Müük | -18M 65M |
Aktsiakasum | -0.05 |
Kasumimarginaal | -10.169 |
Töötajad | 613 |
EBITDA | -2M 3.5M |
Soovitused | Osta |
|---|---|
12 kuu keskmine prognoos | +104.62% upside |
Järgmine tulemuste avaldamine | 6. aug 2026 |
|---|
Turukapital | -38M 79M |
|---|---|
Eelmine avamishind | 9.33 |
Eelmine sulgemishind | 0.63 |
SkinHealth Systems Inc Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Ettevõttest SkinHealth Systems Inc
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.